FDA exploring model master files to expedite generic drug development
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyGenericsPharmaceuticalsRegulatory Intelligence/PolicyResearch, Design and DevelopmentUnited StatesRegulatory NewsJoanne S. EglovitchBiologics/ biosimilars/ vaccinesBiotechnologyGenericsPharmaceuticalsRegulatory Intelligence/PolicyResearch, Design and DevelopmentUnited States